Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA sitewide NIH banner announces an update about terminology used during the agency’s website transition. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study record details, replacing content with a generic error layout and a Home button. This indicates an access restriction rather than an update to the trial information.SummaryDifference18%

- Check53 days agoChange DetectedThe page shows a new revision tag v3.7.0, replacing the previous v3.6.6. This reflects a behind-the-scenes update without changes to the study details presented on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, signaling a minor backend/template update. It does not reflect changes to the study information presented on the page.SummaryDifference0.0%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.